Company file
keyboard_backspaceBack to directoryIdentity
Firalis S.A.
Firalis is a biotechnology company with a mission to improve disease outcome, therapeutic decisions and generate savings in healthcare through biomarker discovery, development and regulatory qualification that ultimately leads to biomarker-based diagnostics. Firalis is active in the field of drug safety, cardiovascular, inflammatory, neurodegenerative and autoimmune diseases.
Firalis develop and sell proprietary CE-marked IVD products in the area of cardiovascular (e.g., heart failures) and neurodegeneration (e.g., Alzheimer Disease and other dementia). Firalis also offers via its affiliates a wide range of biomarker services (preclinical and clinical sample analysis in proteomics.
Contact
17 rue du Fort
68330 Huningue
France
03 89 91 13 20
0389911326
Activities
- Service company
- Research structure
- Analytical Process, Quality assement, Quality Control
- Cleaning
- CGMP
- Cross contamination
- Sterility
- Deviations
- Quality control
- Contaminants detection
- Safety for gene-edited cells : translocation
- Safety for gene-edited cells : anti-nuclease response
- Safety for gene-edited cells : cytokine-independent growth
- Bioproduction
- Bioproduction
- Scale-Up
- Automate manufacturing
- Automated high-throughput microbioreactor system
- Supply chain logistics
- Tracking process
- Monitoring logistics
- Non-GMP pilot batch
- GMP batch
- Ex Vivo & In Vivo Strategy
- Ex Vivo & In Vivo Strategy
- Target cell isolation
- iPS reprogrammation
- Differentiated Cell
- Production Cell
- Safety donor-derived therapies
- Conditionning
- Conditionning
